量子力学/分子力学,分子動力学,構造生物学の研究を組み合わせた酵素の合理的な再設計
PubMedで要約を見る
まとめ
この要約は機械生成です。酵素工学の革新は 新しい化学反応を可能にします 研究者らは,QM/MMとシミュレーションを使用して,-4-hydroxyphenylpyruvate dioxygenase (HPPD) を再設計し,ヒドロキシフェニルアセテート (HPA) のような代替製品を生成する変異体を開発しました.
科学分野
- 生物触媒と酵素工学
- コンピュータ化学
- 構造生物学
背景
- α-ケトグルタレート依存性酸素酵素は重要な酵素ですが,新しい製品のためにそれらを設計することは依然として困難です.
- 酵素の再設計のための広く適用可能な合理的な戦略の開発は,生物触媒のイノベーションにとって不可欠です.
- 4-hydroxyphenylpyruvate dioxygenase (HPPD) は,触媒機構と工学研究のためのモデル酵素として機能する.
研究 の 目的
- 4-hydroxyphenylpyruvate dioxygenase (HPPD) のエンジニアリングのための合理的な戦略を開発し,実証する.
- HPPDの触媒反応経路を理解し,ミュータゲネシスの主要残基を特定する.
- 代替製品,特にヒドロキシフェニルアセテート (HPA) を生産できるHPPDのバリエーションを設計する.
主な方法
- 酵素の活性部位と反応機構をモデル化するための量子力学/分子力学 (QM/MM) の計算.
- 分子動力学 (MD) のシミュレーションで,形状の変化と基板結合を調査する.
- エンジニアリングされたHPPDの変種を作り,特徴づけるためのサイト・ディレクテッド・ミュータジェネシス.
- 設計されたHPPD製品複合体の構造を決定するX線結晶学.
主要な成果
- QM/MMとMDシミュレーションに基づく合理的な再設計戦略がHPPDに成功裏に適用されました.
- この戦略は,HPPDの触媒メカニズムを明らかにし,製品多様化のための経路を特定しました.
- 合成されたHPPD変異体が生成され,原産のホモゲンチサートではなく,代替製品としてヒドロキシフェニルアセテート (HPA) が得られた.
- HPAと複合したHPPD変異体の結晶構造は,重要な触媒中間物質 (HPPD-Fe(IV) -HPA) を確認した.
結論
- 開発された戦略は,HPPDにおける構造と機能の関係をより深く理解します.
- このアプローチは,新しい生物触媒の合理的な開発に一般的に適用可能なプラットフォームを提供します.
- エンジニアリングされたHPPD変種は,新しい化学合成アプリケーションのための変化した製品特異性を持つ酵素を作成する可能性を実証しています.
関連する概念動画
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
For many years, scientists thought that enzyme-substrate binding took place in a simple "lock-and-key" fashion. This model stated that the enzyme and substrate fit together perfectly in one instantaneous step. However, current research supports a more refined view scientists call induced fit. The induced-fit model expands upon the lock-and-key model by describing a more dynamic interaction between enzyme and substrate. As the enzyme and substrate come together, their interaction causes...
Enzymes speed up reactions by lowering the activation energy of the reactants. The speed at which the enzyme turns reactants into products is called the rate of reaction. Several factors impact the rate of reaction, including the number of available reactants. Enzyme kinetics is the study of how an enzyme changes the rate of a reaction.
Scientists typically study enzyme kinetics with a fixed amount of enzyme in the controlled environment of a test tube. When more reactant, or substrate, is...
The theory of catalytically perfect enzymes was first proposed by W.J. Albery and J. R. Knowles in 1976. These enzymes catalyze biochemical reactions at high-speed. Their catalytic efficiency values range from 108-109 M-1s-1. These enzymes are also called 'diffusion-controlled' as the only rate-limiting step in the catalysis is that of the substrate diffusion into the active site. Examples include triose phosphate isomerase, fumarase, and superoxide dismutase.
Most enzymes...
Most chemical reactions in cells require enzymes—biological catalysts that speed up the reaction without being consumed or permanently changed. They reduce the activation energy needed to convert the reactants into products. Enzymes are proteins, that usually work by binding to a substrate—a reactant molecule that they act upon.
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...

